Cargando…
Immune Responses after Vascular Photodynamic Therapy with Redaporfin
Photodynamic therapy (PDT) relies on the administration of a photosensitizer (PS) that is activated, after a certain drug-to-light interval (DLI), by the irradiation of the target tumour with light of a specific wavelength absorbed by the PS. Typically, low light doses are insufficient to eradicate...
Autores principales: | S. Lobo, Ana Catarina, Gomes-da-Silva, Lígia C., Rodrigues-Santos, Paulo, Cabrita, António, Santos-Rosa, Manuel, Arnaut, Luís G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027008/ https://www.ncbi.nlm.nih.gov/pubmed/31906092 http://dx.doi.org/10.3390/jcm9010104 |
Ejemplares similares
-
Redaporfin induces immunogenic cell death by selective destruction of the endoplasmic reticulum and the Golgi apparatus
por: Gomes-da-Silva, Lígia Catarina, et al.
Publicado: (2018) -
Intravenous Single-Dose Toxicity of Redaporfin-Based Photodynamic Therapy in Rodents
por: Rocha, Luis B., et al.
Publicado: (2015) -
Treatment of Head and Neck Cancer with Photodynamic Therapy with Redaporfin: A Clinical Case Report
por: Santos, Lúcio Lara, et al.
Publicado: (2018) -
Photodynamic therapy changes tumour immunogenicity and promotes immune-checkpoint blockade response, particularly when combined with micromechanical priming
por: Lobo, Catarina S., et al.
Publicado: (2023) -
Effects of Photodynamic Therapy with Redaporfin on Tumor Oxygenation and Blood Flow in a Lung Cancer Mouse Model
por: Karwicka, Malwina, et al.
Publicado: (2019)